Evidence map›Paper›PMID 39620522›Full record

ArticleInternational journal of health policy and management2024

To What Extent Can Digital Health Technologies Comply With the Principles of Responsible Innovation? Practice-and Policy-Oriented Research Insights Regarding an Organisational and Systemic Issue.

Hassane Alami, Pascale Lehoux, Sara E Shaw, Marietou Niang, Kathy Malas, Jean-Paul Fortin

Abstract read
In one paragraph

Article in International journal of health policy and management, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Hassane AlamiDepartment of Health Management, Evaluation and Policy, University of Montreal, Montreal, QC, Canada.ORCID 0000-0002-5461-7693
Pascale LehouxDepartment of Health Management, Evaluation and Policy, University of Montreal, Montreal, QC, Canada.ORCID 0000-0001-9482-1800
Sara E ShawNuffield Department of Primary Care Health Sciences, University of Oxford, Oxford, UK.ORCID 0000-0002-7014-4793
Marietou NiangUniversité of Quebec at Rimouski, Levy, QC, Canada.ORCID 0000-0002-3487-9450
Kathy MalasExecutive Office & Research Centre of The University of Montreal Hospital, Montreal, QC, Canada.ORCID 0000-0001-8419-0507
Jean-Paul FortinFaculty of Medicine, Laval University, Quebec, QC, Canada.ORCID 0000-0002-4107-9937

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDigital health technologies (DHTs) have expanded exponentially since the COVID-19 crisis and have prompted questions about their impact across all levels of health systems. Because health organisations and systems play a central role in the success or failure of the transition to more equitable and sustainable societies, the concept of Responsible Innovation in Health (RIH), focused on aligning the processes and outcomes of innovation with societal values, is gaining interest in research, policy, and practice. This study aims to explore enablers and constraints to the development, procurement and/or utilisation of responsible DHTs in health organisations.

methodsSemi-structured interviews were conducted with 29 stakeholders concerned with the development, procurement, and/or utilisation of DHTs in a large Canadian academic health centre. Data were thematically analysed through a mixed deductive-inductive process using the RIH framework.

resultsOur findings highlight that the consideration of RIH principles in the development, procurement, and/or utilisation of DHTs depends mainly on organisational and systemic factors and conditions, namely: (1) the presence of an organisational culture that promotes RIH in its innovation-related practices and processes; (2) availability of material and financial resources as well as expertise in certain fields (eg, environmental sustainability); (3) the evolution of health technology assessment (HTA) practices to include other dimensions beyond effectiveness, safety, and costs; (4) the scope of the regulatory and legal frameworks that govern the approval and use of DHTs; and (5) the role of the market (eg, venture capital) in the design of federal and provincial innovation policies.

conclusionThis study provides insights on practice, policy, and political issues that health organisations may face in the development, procurement, and/or utilisation of responsible DHTs. It can help scholars, practitioners, decision-makers, and industry to create the conditions for a better integration of RIH principles into health organisations and systems.

Indexed as

COVID-19Digital TechnologyHealth PolicyBiomedical TechnologyCanadaDiffusion of InnovationDigital HealthHumansInterviews as TopicOrganizational CultureOrganizational InnovationSARS-CoV-2Stakeholder ParticipationDigital HealthEquityHealth SystemHealth Technology AssessmentResponsible InnovationSustainability

Identifiers

PMID39620522
PMCPMC11549565

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.